Company Black Diamond Therapeutics, Inc. OTC Markets
Equities
BDTX
US09203E1055
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.76 USD | 0.00% | 0.00% | 0.00% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Elizabeth Buck
FOU | Founder | 49 | 13-12-31 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 21-08-08 |
David Epstein
FOU | Founder | 65 | 13-12-31 |
Fang Ni
DFI | Director of Finance/CFO | 37 | 20-08-03 |
Sergey Yurasov
CTO | Chief Tech/Sci/R&D Officer | 55 | 22-05-31 |
Chief Operating Officer | 59 | 19-05-28 | |
Julie Seidel
IRC | Investor Relations Contact | - | - |
Melanie Morrison
PRN | Corporate Officer/Principal | 49 | 22-09-30 |
Human Resources Officer | 52 | 22-02-21 | |
Erika Jones
AUD | Comptroller/Controller/Auditor | 39 | 19-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Epstein
FOU | Founder | 65 | 13-12-31 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 21-08-08 |
Ali Behbahani
BRD | Director/Board Member | 48 | 18-11-30 |
Garry Menzel
BRD | Director/Board Member | 59 | 13-12-31 |
Kapil Dhingra
BRD | Director/Board Member | 64 | 21-01-18 |
Samarth Kulkarni
BRD | Director/Board Member | 45 | 19-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 56,252,794 | 54,935,052 ( 97.66 %) | 0 | 97.66 % |
Company contact information
Black Diamond Therapeutics, Inc.
One Main Street 14th floor
02142, Cambridge
+
http://www.blackdiamondtherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.87% | 118B | |
+10.12% | 106B | |
-10.03% | 23.4B | |
-1.46% | 22.1B | |
-9.68% | 18.34B | |
-41.70% | 16.59B | |
-14.89% | 15.97B | |
+5.96% | 14.03B | |
+18.11% | 11.67B |
- Stock Market
- Equities
- BDTX Stock
- BDTX Stock
- Company Black Diamond Therapeutics, Inc.